Edit |   |
---|---|
Antigenic Specificity | CD137, Human |
Clone | REA765 |
Host Species | Recombinant Human |
Reactive Species | human, nonhuman primate |
Isotype | IgG1 |
Format | Vio Bright FITC conjugate |
Size | 100 tests in 200 µL |
Concentration | 1:50 |
Applications | Flow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | CD137 Antibody, anti-human, Vio® Bright FITC, REAfinity™. Clone REA765 recognizes the human CD137 antigen, a 30 kDa glycoprotein of the tumor necrosis factor (TNF) receptor superfamily, a group of cytokines that can cause cell death (apoptosis). CD137 is mainly expressed on activated CD4+ and CD8+ T cells, activated B cells, and natural killer cells, but can also be found on resting monocytes and dendritic cells. As a costimulatory molecule it is involved in the activation and survival of CD4+ or CD8+ T cells and NK cells. CD137 has been described to be a suitable marker for antigen-specific activation of human CD8+ T cells, as it is not expressed on resting CD8+ T cells and its expression is reliably induced after 24 hours of stimulation. | Additional information: Clone REA765 displays negligible binding to Fc receptors. |
Immunogen | n/a |
Other Names | CDw137, TNFRSF9, ILA, Ly-63, 4-1BB, 41BB |
Gene, Accession # | Gene ID: 3604 |
Catalog # | 130-110-765 |
Price | $395 |
Order / More Info | CD137, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
Product Specific References | Alderson, M. R. et al. (1994) Molecular and biological characterization of human 4-1BB and its ligand. Eur. J. Immunol. 24 (9): 2219-2227. | Wolfl, M. et al. (2007) Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. Blood 110: 201-210. |